SLC52A1
protein-codingsolute carrier family 52 member 1, the group of Solute carrier family 52
Gene summary
Biological redox reactions require electron donors and acceptor. Vitamin B2 is the source for the flavin in flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) which are common redox reagents. This gene encodes a member of the riboflavin (vitamin B2) transporter family. Haploinsufficiency of this protein can cause maternal riboflavin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jan 2013]
- GPR172B
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~19.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014013
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0004573
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0004573
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014013
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014013
Submitter: ClinGen
SLC52A1 was reported in relation to autosomal dominant maternal riboflavin deficiency in 2011 (Ho et al., PMID 21089064). At least 5 variants (e.g. large deletion, intronic, missense) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 5 probands in 3 publications (PMIDs 21089064, 29122468, 37510312). This gene-disease association is supported by expression studies and in vitro functional assays. In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This gene-disease pair was originally evaluated by the Fatty Acid Oxidation Disorders GCEP on October 12, 2018. It was reevaluated on May 22, 2026. As a result of this reevaluation, the classification did not change.
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Neurologic
Intervention: Biochemical
Rationale: One individual with a heterozygous deletion has been reported, and this was postulated as contributing to transient neonatal-onset glutaric aciduria Type 2 in this individual's offspring,which was reported as being effectively treated by riboflavin therapy
Comments: Theoretically, biallelic variants could contribute to disease similar to that arising from variants in SLC52A2 or SLC52A3
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC52A1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017986.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 73 | 2 | 77 | ||
| missense | 152 | 10 | 162 | |||
| nonsense | 2 | 2 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 13 | 1 | 14 | |||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 170 | 84 | 2 | 256 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060456.3 | 4 | MANE Select | |
| Ensembl | ENSP00000254853.5 | 4 | MANE Select | |
| RefSeq | NP_001098047.1 | 4 | Standard | |
| Ensembl | ENSP00000399979.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism
- Vitamin B2 (riboflavin) metabolism
- Metabolism of water-soluble vitamins and cofactors
- Metabolism of vitamins and cofactors
Biological Process
- riboflavin metabolic process
- riboflavin transport
- viral entry into host cell
Molecular Function
- virus receptor activity
- riboflavin transmembrane transporter activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000424747
- Coding exons
- 4
- Length
- 19410
- Individuals with no LoFs
- 125646
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 101
- Defined
- 125747
- p
- 0.000402
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0538 | 251 | 253 | 0.990 | 0.0000137 | 2781 |
| Missense (PolyPhen) | 89 | 84.03 | 1.0591 | 1032 | ||
| Synonymous | 0.0658 | 121 | 122 | 0.992 | 0.00000694 | 1103 |
| Loss of Function | 0.388 | 9 | 10.3 | 0.870 | 4.44e-7 | 116 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0020 | 0.0020 | notable |
| Latino/Admixed American | 0.00075 | 0.00067 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00027 | 0.00024 | rare |
| South Asian | 0.00043 | 0.00042 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Riboflavin transporter. Riboflavin transport is Na(+)- independent but moderately pH-sensitive. Activity is strongly inhibited by riboflavin analogs, such as lumiflavin. Weakly inhibited by flavin adenine dinucleotide (FAD). In case of infection by retroviruses, acts as a cell receptor to retroviral envelopes similar to the porcine endogenous retrovirus (PERV-A). {ECO:0000269|PubMed:12740431, ECO:0000269|PubMed:20463145}.;
Recessive Scores
- pRec
- 0.0920
Intolerance Scores
- RVIS EVS
- 0.31
- RVIS percentile EVS
- 72.66
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |